What cortisol laboratory test should be added if a patient has resistant hypertension (HTN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For patients with resistant hypertension, I recommend adding a 1 mg dexamethasone suppression test (DST) as the preferred screening test for identifying autonomous cortisol secretion, as well as a plasma aldosterone-to-renin ratio (ARR) test to evaluate for primary aldosteronism. This approach is based on the most recent and highest quality evidence from the study published in 2023 1, which suggests that the 1 mg DST is the preferred screening test for identifying autonomous cortisol secretion. The ARR test is also recommended as the initial test for patients with hypertension and/or hypokalemia in whom primary aldosteronism is suspected, as stated in the same study 1. Additionally, the 2018 guideline from the American College of Cardiology/American Heart Association task force on clinical practice guidelines also supports the use of the ARR test for screening primary aldosteronism in patients with resistant hypertension 1. It is essential to ensure that the patient has adequate potassium levels and has discontinued medications that can interfere with results, such as spironolactone, eplerenone, and other diuretics, for at least 2-4 weeks when possible. The rationale for these tests is that excess mineralocorticoids or glucocorticoids can cause resistant hypertension through increased sodium retention, volume expansion, and vascular sensitivity to catecholamines. Some key points to consider when interpreting the results of these tests include:

  • A serum cortisol level of >138 nmol/L after the 1 mg DST indicates evidence of cortisol hypersecretion, while a level of 51-138 nmol/L suggests possible autonomous cortisol secretion 1.
  • An ARR of 20 ng/dL per ng/mL/hr has excellent sensitivity and specificity (>90%) for confirming hyperaldosteronism 1. If these initial tests are abnormal, additional confirmatory tests such as a 24-hour urinary free cortisol test and/or late-night salivary cortisol may be needed before proceeding to imaging studies to localize the source of hormone excess.

From the Research

Resistant Hypertension and Cortisol Laboratory Tests

To diagnose the underlying cause of resistant hypertension, several laboratory tests can be considered.

  • The 24-hour urine free cortisol (UFC) test is a reliable method for establishing the diagnosis of Cushing's syndrome, a condition that can cause resistant hypertension 2.
  • The low-dose dexamethasone suppression test is another test used to diagnose Cushing's syndrome 2.
  • Plasma aldosterone to renin ratio is a useful screening tool for primary aldosteronism, a common cause of resistant hypertension 3.

Cortisol Laboratory Tests

The following cortisol laboratory tests can be added if a patient has resistant hypertension:

  • 24-hour urine free cortisol (UFC) test, which can be measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) or immunoassay 4
  • Low-dose dexamethasone suppression test 2
  • Plasma cortisol measurement 2

Rationale

These tests can help identify underlying causes of resistant hypertension, such as Cushing's syndrome or primary aldosteronism, which can inform treatment decisions 5, 6, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Resistant hypertension: who and how to evaluate.

Current opinion in cardiology, 2009

Research

Diagnosis and management of resistant hypertension.

Heart (British Cardiac Society), 2024

Research

Resistant hypertension: challenges in everyday practice.

Polish archives of internal medicine, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.